Genomic and Antigenic Differences Between Monkeypox Virus and Vaccinia Vaccines: Insights and Implications for Vaccinology
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041428 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jane Shen-Gunther und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Oncology & Molecular Medicine, Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, T…. Hauptthemen laut MEDLINE: Vaccinia virus, Monkeypox virus, Antigens, Viral, Genome, Viral. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amid the current multi-country mpox outbreak, analyzing monkeypox virus (MPXV) and vaccinia virus (VACV) genomes is vital for understanding evolutionary processes that may impact vaccine efficacy and design. This study aimed to elucidate the phylogenetic relationships and structural features of viral antigens, which are crucial for developing effective vaccines. By aligning 1903 MPXV genomes from the NCBI Virus repository (released between 2022 and 2024), an increase in phylogenetic diversity was observed compared to previous studies. These genomes were grouped into Clade I (25 genomes) and Clade IIB (1898 genomes), with a new Clade I sub-lineage emerging from samples collected in Sud-Kivu province, Democratic Republic of the Congo (DRC). Comparing six key MPXV neutralization determinants (A29, A35, B6, E8, H3, and M1) of a novel 2024 Clade I MPXV isolate to those of the 1996 Zaire isolate revealed remarkable sequence conservation despite spanning 28 years. Homology-based modeling of the Clade I MPXV antigens (A29, A35, E8, H3, and M1) showed high-match identities (84% to 99%) with VACV templates (current mpox vaccine), with several amino acid variants near potential antibody binding sites. Phylogenomic analysis, combined with structural modeling and variant profiling, has yielded valuable insights into the virus and vaccine, guiding vaccine design and functional studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gynecologic Oncology & Molecular Medicine, Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
- Department of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA.
- South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, San Antonio, TX 78249, USA.
ORCID-Profile: Jane Shen-Gunther, Yufeng Wang
Zitieren
APA
Shen-Gunther, J., Cai, H., & Wang, Y. (2025). Genomic and Antigenic Differences Between Monkeypox Virus and Vaccinia Vaccines: Insights and Implications for Vaccinology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041428
Vancouver
Shen-Gunther J, Cai H, Wang Y. Genomic and Antigenic Differences Between Monkeypox Virus and Vaccinia Vaccines: Insights and Implications for Vaccinology. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041428
BibTeX
@article{ShenGunther2025,
author = {Shen-Gunther, Jane and Cai, Hong and Wang, Yufeng},
title = {Genomic and Antigenic Differences Between Monkeypox Virus and Vaccinia Vaccines: Insights and Implications for Vaccinology},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041428}
}
EUVIMED